down arrow

Walvax Biotechnology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000WN2
CNY
11.71
-0.05 (-0.43%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Walvax Biotechnology Co., Ltd.
Why is Walvax Biotechnology Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 16.33% and Operating profit at -205.34% over the last 5 years
2
With a fall in Net Sales of -17.19%, the company declared Very Negative results in Mar 25
  • The company has declared negative results for the last 7 consecutive quarters
  • NET SALES(9M) At CNY 1,837.23 MM has Grown at -27.36%
  • NET PROFIT(9M) At CNY -43.3 MM has Grown at -117.45%
  • PRE-TAX PROFIT(Q) At CNY -28.77 MM has Fallen at -120.26%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -20.09%, its profits have fallen by -121.8%
  • At the current price, the company has a high dividend yield of 0.1
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -20.09% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Walvax Biotechnology Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Walvax Biotechnology Co., Ltd.
-18.11%
0.04
36.75%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
16.33%
EBIT Growth (5y)
-205.34%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.37
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
11.25%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.84%
ROE (avg)
9.19%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.91
EV to EBIT
-78.43
EV to EBITDA
71.81
EV to Capital Employed
2.22
EV to Sales
6.26
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
-2.83%
ROE (Latest)
-1.13%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
INVENTORY TURNOVER RATIO(HY)

Highest at 0.82%

-29What is not working for the Company
NET SALES(9M)

At CNY 1,837.23 MM has Grown at -27.36%

NET PROFIT(9M)

At CNY -43.3 MM has Grown at -117.45%

PRE-TAX PROFIT(Q)

At CNY -28.77 MM has Fallen at -120.26%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.94%

RAW MATERIAL COST(Y)

Grown by 5.58% (YoY

Here's what is working for Walvax Biotechnology Co., Ltd.
Inventory Turnover Ratio
Highest at 0.82%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Walvax Biotechnology Co., Ltd.
Net Sales
At CNY 458.67 MM has Fallen at -22.99%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY -28.77 MM has Fallen at -120.26%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY -11.49 MM has Fallen at -116.22%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Debtors Turnover Ratio
Lowest at 0.94% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Net Sales
Lowest at CNY 458.67 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Raw Material Cost
Grown by 5.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."